RealSource
Residential, Inc.
(
A Development Stage Company)
Consolidated Statements of Cash Flows
|
|
For the Three Months Ended December 31,
2013
|
|
|
For the Three Months Ended December 31,
2012
|
|
|
For the Fiscal Year Ended September 30,
2013
|
|
|
For the Fiscal Year Ended September 30,
2012
|
|
|
For the Period from June 14, 2004 (inception) through
December 31, 2013
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(39,921
|
)
|
|
$
|
(29,217
|
)
|
|
$
|
(35,818
|
)
|
|
$
|
(1,763
|
)
|
|
$
|
(7,185,710
|
)
|
Adjustments to reconcile net loss to net cash used in
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forgiveness of debt
|
|
|
—
|
|
|
|
—
|
|
|
|
(32,079
|
)
|
|
|
—
|
|
|
|
(32,079
|
)
|
Amortization
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
133,600
|
|
Accretion of convertible debenture
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
302,808
|
|
Shares issued or to be issued for services
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,487,236
|
|
Stock-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,658,590
|
|
Compensation shares
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
25,000
|
|
Deferred income tax
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(57,415
|
)
|
Asset impairment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
59,010
|
|
Gain on sale of subsidiary
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(126,515
|
)
|
Loss from sale of intellectual property
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
78,570
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
—
|
|
|
|
1,375
|
|
|
|
3,500
|
|
|
|
(3,104
|
)
|
|
|
(2,781
|
)
|
Other receivables
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(10,259
|
)
|
Other receivables
|
|
|
(11,071
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(11,071
|
)
|
Accounts payable and accrued liabilities
|
|
|
1,456
|
|
|
|
3,772
|
|
|
|
18,851
|
|
|
|
(11,937
|
)
|
|
|
276,290
|
|
Due to related parties
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
271,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(49,536
|
)
|
|
|
(24,070
|
)
|
|
|
(45,546
|
)
|
|
|
(16,804
|
)
|
|
|
(3,132,742
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for acquisition of PPT shares
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(51,507
|
)
|
Proceeds from the sale of subsidiary
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1
|
|
Deposit
|
|
|
(1,537,636
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,537,636
|
)
|
Purchase of equipment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(22,764
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(1,537,636
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,611,906
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of convertible notes payable
|
|
|
2,110,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3,110,000
|
|
Proceeds from issuance of common shares, net
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
35,000
|
|
|
|
2,030,345
|
|
Advances from (repayment made to)
related party
|
|
|
—
|
|
|
|
20,823
|
|
|
|
42,823
|
|
|
|
(25,000
|
)
|
|
|
131,310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
2,110,000
|
|
|
|
20,823
|
|
|
|
42,823
|
|
|
|
10,000
|
|
|
|
5,271,655
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes
on cash
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,486
|
)
|
|
|
(2,590
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash
|
|
|
522,828
|
|
|
|
(3,247
|
)
|
|
|
(2,723
|
)
|
|
|
(8,290
|
)
|
|
|
524,417
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at beginning of period
|
|
|
1,589
|
|
|
|
4,312
|
|
|
|
4,312
|
|
|
|
12,602
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at end of period
|
|
$
|
524,417
|
|
|
$
|
1,065
|
|
|
$
|
1,589
|
|
|
$
|
4,312
|
|
|
$
|
524,417
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flows information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Income tax paid
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for debt
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,000
|
|
|
$
|
—
|
|
|
$
|
35,000
|
|
See accompanying notes to the consolidated
financial statements.
RealSource Residential, Inc.
(A Development Stage Company)
December 31, 2013, September 30, 2013 and
2012
Notes to the Consolidated Financial Statements
Note 1 - Organization and Operations
Upstream Biosciences, Inc.
Upstream Biosciences, Inc. (“Upstream
Biosciences”) was incorporated on March 20, 2002 under the laws of the State of Nevada. Upstream Biosciences engaged in developing
technology relating to biomarker identification, disease susceptibility and drug response areas of cancer.
Change in Control
On May 24, 2013, Charles El-Moussa and Six
Capital Limited (“Six Capital”)(collectively, the “Sellers”), as majority stockholders of Upstream Biosciences,
Inc., a Nevada corporation, and RealSource Acquisitions Group, LLC, a Utah limited liability company, and Chesterfield Faring Ltd.,
a New York corporation (collectively, the “Purchasers”), entered into a Securities Purchase Agreement (the “Agreement”)
pursuant to which the Sellers agreed to sell to the Purchasers an aggregate of 10,778,081 shares (representing approximately 90%
of the issued and outstanding voting securities of the Company) of common stock of the Company (the “Common Stock”) for
$175,000 in cash from the personal funds of the Purchasers (the “Transaction”).
RealSource Residential, Inc.
On July 11, 2013, Upstream Biosciences entered
into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which Upstream Biosciences merged with its
newly formed, wholly owned subsidiary, RealSource Residential, Inc., a Nevada corporation (“Merger Sub” and such merger
transaction, the “Merger”) with the Company remaining as the surviving corporation under the name “RealSource Residential,
Inc.” (the “Surviving Company” or the “Company”). Upon the consummation of the Merger, the separate existence
of Merger Sub ceased and shareholders of the Company became shareholders of the surviving company named RealSource Residential,
Inc. The Merger was effective on Monday, July 15, 2013 (the “Effective Date”) and was approved by the Financial Industry
Regulatory Authority on August 5, 2013.
The Company has been engaged in real estate
brokerage and management based since the merger with RealSource Residential, Inc.
Note 2 - Significant and Critical Accounting Policies and Practices
The Management of the Company is responsible
for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application.
Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition
and results and require management’s most difficult, subjective, or complex judgments, often as a result of the need to make estimates
about the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices
are disclosed below as required by generally accepted accounting principles.
Basis of presentation
The Company’s financial statements have been
prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Development Stage
Company
The Company is a development stage company
as defined by section 915-10-20 of the FASB Accounting Standards Codification. Although the Company recognized nominal amount of
revenues, it is still devoting substantially all of its efforts on establishing the business and its planned principal operations
have not commenced. All losses accumulated since inception have been considered as part of the Company’s development stage activities.
Fiscal Year-End
The Company elected December 31 as
its fiscal year-end date upon formation. On July 9, 2013, the Company’s board of directors voted to change
the Company’s fiscal year end from September 30th to December 31st. The Company’s 2014 fiscal year will
begin on January 1, 2014 and end on December 31, 2014. As a result of this change, the Company is filing a
Transition Report on Form 10-K for the three-month transition period ended December 31, 2013.
Use of Estimates and Assumptions and
Critical Accounting Estimates and Assumptions
The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).
Critical accounting estimates are estimates
for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly
uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or
operating performance is material. The Company’s critical accounting estimates and assumptions affecting the financial statements
were:
|
(i)
|
Assumption as a going concern
: Management assumes that the Company will continue as a going
concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course
of business;
|
|
(ii)
|
Valuation allowance for deferred tax assets
: Management assumes that the realization of
the Company’s net deferred tax assets resulting from its net operating loss (“NOL”) carry–forwards for Federal
income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the
potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption
based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional
funds to support its daily operations by way of a public or private offering, among other factors.
|
|
(iii)
|
Estimates and assumptions used in valuation of equity
instruments
: Management estimates expected term of share options and similar instruments, expected volatility of the
Company’s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s)
to value share options and similar instruments.
|
These significant accounting estimates or assumptions
bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates
or assumptions are difficult to measure or value.
Management bases its estimates on historical
experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole
under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources.
Management regularly evaluates the key factors
and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical
experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.
Actual results could differ from those estimates.
Reclassification
Certain amounts in the prior period financial
statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported
income or losses.
Principles of Consolidation
The Company applies the guidance of Topic 810
“Consolidation” of the FASB Accounting Standards Codification (“ASC”) to determine whether and how to consolidate
another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has
a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent, the majority
owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation
by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8
the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general
rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another
entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership,
for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned
subsidiaries, if any, in which the parent’s power to control exists.
The Company’s consolidated subsidiaries and/or
entities are as follows:
Name of consolidated
subsidiary or entity
|
|
State or other jurisdiction of incorporation or organization
|
|
Date of incorporation or formation
(date of acquisition, if applicable)
(date of disposition, if applicable)
|
|
Attributable interest
|
|
|
|
|
|
|
|
Upstream Biosciences
Inc.
|
|
Canada
|
|
June 14, 2004
(February 24, 2006)
(February 15, 2011)
|
|
100%
|
|
|
|
|
|
|
|
Pacific Pharma Technologies, Inc.
|
|
British Columbia
|
|
(August 24, 2007)
(December
14, 2009)
|
|
100%
|
The consolidated financial statements include
all accounts of the Company as of September 30, 2013 and 2012 and for the reporting periods then ended.
All inter-company balances and transactions
have been eliminated.
Fair Value of Financial Instruments
The Company follows paragraph 825-10-50-10
of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37
of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments.
Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and
expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related
disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used
to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted)
in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair
value hierarchy defined by Paragraph 820-10-35-37 are described below:
Level 1
|
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
|
|
|
Level 2
|
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
|
|
|
Level 3
|
Pricing inputs that are generally observable inputs and not corroborated by market data.
|
Financial assets are considered
Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and
at least one significant model assumption or input is unobservable.
The fair value hierarchy
gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority
to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described
above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
The carrying amounts of the
Company’s financial assets and liabilities, such as cash, subscription receivable, interest receivable and accounts payable
and accrued liabilities, approximate their fair values because of the short maturity of these instruments.
The Company’s
convertible notes payable approximate the fair value of such instruments based upon management’s best estimate of interest
rates that would be available to the Company for similar financial arrangements at December 31, 2013.
Transactions involving related parties cannot
be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not
exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were
consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.
Cash Equivalents
The Company considers all highly liquid investments
with maturities of three months or less at the time of purchase to be cash equivalents.
Related Parties
The Company follows subtopic 850-10 of the
FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.
Pursuant to Section 850-10-20 the related parties
include a. affiliates of the Company; b. entities for which investments in their equity securities would be required,
absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted
for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing
trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the
Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management
or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its
own separate interests; and g. other parties that can significantly influence the management or operating policies of the
transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other
to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.
The financial statements shall include disclosures
of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the
ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined
financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s)
involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for
each of the periods for which income statements are presented, and such other information deemed necessary to an understanding
of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods
for which income statements are presented and the effects of any change in the method of establishing the terms from that used
in the preceding period; and d. amounts due from or to
related parties
as of the date of each
balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Commitment and Contingencies
The Company follows subtopic 450-20 of the
FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the
financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future
events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise
of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims
that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as
well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates
that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated
liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency
is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability,
and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are generally
not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based
upon information available at this time, that these matters will have a material adverse effect on the Company’s financial position,
results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect
the Company’s business, financial position, and results of operations or cash flows.
Revenue Recognition
The Company follows paragraph
605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized
or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are
met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to
the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.
Foreign Currency Transactions
The Company applies the guidelines as set
out in Section 830-20-35 of the FASB Accounting Standards Codification (“Section 830-20-35”) for foreign currency
transactions. Pursuant to Section 830-20-35 of the FASB Accounting Standards Codification, foreign currency transactions are
transactions denominated in currencies other than U.S. Dollar, the Company’s reporting currency or Canadian dollar, the
Company’s Canadian subsidiaries’ functional currency. Foreign currency transactions may produce receivables or payables that
are fixed in terms of the amount of foreign currency that will be received or paid. A change in exchange rates between the
functional currency and the currency in which a transaction is denominated increases or decreases the expected amount of
functional currency cash flows upon settlement of the transaction. That increase or decrease in expected functional currency
cash flows is a foreign currency transaction gain or loss that generally shall be included in determining net income for the
period in which the exchange rate changes. Likewise, a transaction gain or loss (measured from the transaction date or the
most recent intervening balance sheet date, whichever is later) realized upon settlement of a foreign currency transaction
generally shall be included in determining net income for the period in which the transaction is settled. The exceptions to
this requirement for inclusion in net income of transaction gains and losses pertain to certain intercompany transactions and
to transactions that are designated as, and effective as, economic hedges of net investments and foreign currency
commitments. Pursuant to Section 830-20-25 of the FASB Accounting Standards Codification, the following shall apply to all
foreign currency transactions of an enterprise and its investees: (a) at the date the transaction is recognized, each asset,
liability, revenue, expense, gain, or loss arising from the transaction shall be measured and recorded in the functional
currency of the recording entity by use of the exchange rate in effect at that date as defined in section 830-10-20 of the
FASB Accounting Standards Codification; and (b) at each balance sheet date, recorded balances that are denominated in
currencies other than the functional currency or reporting currency of the recording entity shall be adjusted to reflect the
current exchange rate.
Stock-Based Compensation for Obtaining
Employee Services
The Company accounts for its stock based compensation
in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles
of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph
718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received
for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value
of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of
the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable
that performance will occur.
The fair value of options
and
similar instruments
is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of
assumptions for inputs are as follows:
·
|
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the
simplified method, i.e., expected term = ((vesting term + original contractual term) / 2)
, if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.
|
|
|
·
|
Expected
volatility of the entity’s shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a
thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable
for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has
selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.
The Company uses the average historical volatility of the comparable companies over the expected contractual life of the
share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly
or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility
calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid
and asked quotes and lack of consistent trading in the market.
|
·
|
Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.
|
|
|
·
|
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.
|
The Company’s policy is to recognize compensation
cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service
period for the entire award.
Equity Instruments Issued to Parties
Other Than Employees for Acquiring Goods or Services
The Company accounts for equity instruments
issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting
Standards Codification (“Sub-topic 505-50”).
Pursuant to ASC Section 505-50-30, all transactions
in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the
fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance
is complete or the date on which it is probable that performance will occur.
The fair value of option or warrant award is
estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as
follows:
·
|
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder’s expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder’s expected exercise behavior. The contractual term of share options or similar instruments is used as expected term of share options or similar instruments for the Company if it is a newly formed corporation.
|
·
|
Expected volatility of the
entity’s shares and the method used to estimate it. An entity that uses a method that employs different volatilities during
the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility. A
thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable
for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has
selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.
The Company uses the average historical volatility of the comparable companies over the expected contractual life of the
share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly
or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility
calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid
and asked quotes and lack of consistent trading in the market.
|
·
|
Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.
|
·
|
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.
|
Pursuant to ASC paragraph 505-50-25-7,
if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for
goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the
elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached.
A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether
the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity
under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1,
a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable
equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific
performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity
by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the
balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other
than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date
for transactions that are within the scope of this Subtopic.
Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an
entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period
of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions.
Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid
cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments.
A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise
expires unexercised.
Pursuant to ASC paragraph 505-50-30-S99-1,
if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity
instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are
not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should
be recorded.
Income Tax Provision
The Company accounts for income taxes under
Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based
upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax
rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation
allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets
and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in the statements of operations in the period that includes the enactment date.
The Company adopted section 740-10-25 of the
FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether
tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25,
the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position
will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized
in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty
percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition,
classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
The estimated future tax effects of temporary
differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit
carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance
sheets and provides valuation allowances as management deems necessary.
Management makes judgments as to the interpretation
of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the
Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion,
adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates,
additional allowances or reversals of reserves may be necessary.
Uncertain Tax Positions
The Company did not take any uncertain tax
positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for
the reporting period ended December 31, 2013.
Limitation on Utilization of NOLs due
to Change in Control
Pursuant to the Internal Revenue Code Section
382 (“Section 382”), certain ownership changes may subject the NOL’s to annual limitations which could reduce or defer
the NOL. Section 382 imposes limitations on a corporation’s ability to utilize NOLs if it experiences an “ownership change.”
In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock
of a corporation by more than 50 percentage points over a three-year period. In the event of an ownership change, utilization of
the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time
of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later
years. The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company
to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused,
reducing or eliminating the benefit of such NOLs.
Net Income (Loss) per Common
Share
Net income (loss) per common share is computed
pursuant to Section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed
by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net
income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock
and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur
from common shares issuable through contingent share arrangements, stock options and warrants.
The following table shows the potentially outstanding
dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:
|
|
Potentially Outstanding Dilutive
Common Shares
|
|
|
|
|
|
|
|
For the Reporting Period Ended
December 31, 2013
|
|
|
For the Reporting Period Ended
December 31, 2012
|
|
|
|
|
|
|
(Unaudited)
|
|
Convertible Notes Payable Shares and Related Warrant Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On December 9, 2013, the Company consummated the closing (the “Closing”) of a private placement offering (the “Offering”) of 231 units (“Units”) for $10,000 per Unit, for aggregate gross proceeds of $2,310,000. No placement agents or brokers were utilized by the Company in connection with the Offering. Each Unit consists of: (i) a $10,000 face value 12% Series A Senior Unsecured Convertible Promissory Note of the Company (collectively, the “Notes”) convertible into shares of Common Stock at $0.50 per share, and (ii) one detachable Common Stock Purchase Warrant (collectively, the “Warrants”) to purchase 10,000 shares (the “Warrant Shares”) of common stock of the Company (the “Common Stock”) with an exercise price of $1.00 per share expiring five years from the date of issuance.
|
|
|
(i) 4,620,000
(ii) 2,310,000
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Sub-total: convertible notes payable shares and related warrant shares
|
|
|
6,930,000
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Total potentially outstanding dilutive common shares
|
|
|
6,930,000
|
|
|
|
—
|
|
Cash Flows Reporting
The Company adopted paragraph 230-10-45-24
of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether
they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or
reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification
to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities
by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating
cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.
The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time
of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in
the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing
and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB
Accounting Standards Codification.
Subsequent Events
The Company follows the guidance in Section
855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent
events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards
Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users,
such as through filing them on EDGAR.
Recently Issued Accounting Pronouncements
In February 2013, the FASB issued ASU No.
2013-02
,
“
Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive
Income.
” The ASU adds new disclosure requirements for items reclassified out of accumulated other comprehensive
income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years
beginning after December 15, 2013.
In February 2013, the Financial Accounting
Standards Board, or FASB, issued ASU No.
2013-04
, “
Liabilities (Topic 405): Obligations
Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting
Date
.” This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and
several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The
ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.
In March 2013, the FASB issued ASU No.
2013-05
,
“
Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition
of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity
.” This ASU
addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in
a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity
or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released
into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively
for fiscal years, and interim periods within those years, beginning after December 15, 2013.
In March 2013, the FASB issued ASU
2013-07
,
“Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting.”
The amendments require an entity
to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent
when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by
the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan
will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy).
If a plan for liquidation was specified in the entity’s governing documents from the entity’s inception (for example, limited-life
entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the
plan for liquidation that was specified at the entity’s inception. The amendments require financial statements prepared using the
liquidation basis of accounting to present relevant information about an entity’s expected resources in liquidation by measuring
and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation
of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in
settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent
during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply
the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.
Management does not believe that any other
recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying
financial statements.
Note 3 – Going Concern
The financial statements have been prepared
assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets,
and liquidation of liabilities in the normal course of business.
As reflected in the consolidated
financial statements, the Company had a deficit accumulated during the development stage at December 31, 2013, a net loss and
net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the
Company’s ability to continue as a going concern.
The Company is attempting to commence
operations and generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the
Company’s daily operations. While the Company believes in the viability of its strategy to generate sufficient revenue and in
its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a
going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue
and its ability to raise additional funds.
The financial statements do not include any
adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities
that might be necessary should the Company be unable to continue as a going concern.
Note 4 – Convertible Notes
On December 9, 2013, the Company
consummated the closing (the “Closing”) of a private placement offering (the “Offering”) of 231 units
(“Units”) for $10,000 per Unit, for aggregate gross proceeds of $2,310,000. No placement agents or brokers
were utilized by the Company in connection with the Offering. Each Unit consists of: (i) a $10,000 face value 12% Series A
Senior Unsecured Convertible Promissory Note of the Company convertible into common shares at $0.50 per share (collectively,
the “Notes”), and (ii) one detachable Common Stock Purchase Warrant (collectively, the “Warrants”), each
to purchase 10,000 shares (the “Warrant Shares”) of common stock of the Company (the “Common Stock”)with
an exercise price of $1.00 per share expiring five years from the date of issuance. In connection with the Closing, the
Company entered into definitive subscription agreements (the “Subscription Agreements”) with twenty nine (29)
accredited investors. The Notes accrue interest at 12% per year and have a maturity date of December 9, 2015. The Notes will
be automatically converted into shares of the Company’s Common Stock at the then applicable conversion price in the event
that the 90-day trading volume weighted average price per share of the Common Stock exceeds $1.50 per share at any time
during the term of the Notes.
Twenty units or $200,000 in aggregate were
issued but not collected at December 31, 2013. The receivable is shown as Subscriptions Receivable as a current asset since the
money was received by the Company on January 13, 2014.
The Company estimated the relative fair value
of the warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
|
|
December 9, 2013
|
|
|
|
|
|
Expected life (year)
|
|
|
5
|
|
|
|
|
|
|
Expected volatility (*)
|
|
|
61.39
|
%
|
|
|
|
|
|
Expected annual rate of quarterly dividends
|
|
|
0.00
|
%
|
|
|
|
|
|
Risk-free rate(s)
|
|
|
1.54
|
%
|
|
*
|
As a thinly traded entity it is not practicable for the Company to estimate the expected
volatility of its share price. The Company selected five (5) comparable public companies listed on NYSE MKT and NASDAQ
Capital Market within real estate brokerage and management industry which the Company engages in to calculate the expected
volatility. The Company calculated those five (5) comparable companies’ historical volatility over the expected life of the
options or warrants and averaged them as its expected volatility.
|
The estimated relative fair value of the warrants
was deminimus at the date of issuance using the Black-Scholes Option Pricing Model.
Note 6 – Related Party Transactions
Related Parties
Related parties with whom the Company had transactions
are:
Related Parties
|
|
Relationship
|
|
|
|
Nathan Hanks
|
|
Chairman, significant stockholder and director
|
|
|
|
Michael Anderson
|
|
President and CEO, significant stockholder and director
|
|
|
|
V. Kelly Randall
|
|
Chief Operating Officer, Chief Financial Officer and Director
|
|
|
|
RS Cambridge Apartments, LLC
|
|
An entity controlled and partially owned by the Chairman, President and CEO of the Company
|
Purchase and Sale agreement- RS Cambridge
Apartments, LLC
Proceeds from the Offering were used to (i)
acquire a $2.85 million face value subordinated mortgage note secured by the Cambridge Apartments in Gulfport, Mississippi (the
“Property”) for approximately $1,073,000 (the “B Note”) and (ii) fund (in the amount of approximately $739,000)
certain costs associated with a refinancing of the senior mortgage indebtedness encumbering the Property (which refinancing occurred
concurrently with the Company’s acquisition of the B Note). The remaining proceeds from the Offering (in the amount of approximately
$772,000) will be used for the general working capital of the Company. The Cambridge Property is owned by RS Cambridge Apartments,
LLC (the “Property Owner”). Nathan Hanks and Michael Anderson, officers and directors of the Company, own 10% of the
outstanding membership interests of the Property Owner.
Immediately upon the acquisition of the B Note,
the Company converted the B Note into a right of first refusal and option (the “Option”) in the amount of approximately
$1,538,000 (the “Option Payment”), which is the amount of funds from the Offering used to purchase the B Note and otherwise
support the refinancing of the Property.
To memorialize the Option, on December 9, 2013,
the Company entered into a Right of First Refusal and Option Agreement (the “Option Agreement”) with the Property Owner.
The Option affords the Company the right to acquire the Property within five (5) years after the Closing at the fair value of the
Property as negotiated between the Company and the Property Owner. In addition, under the Option, if the Property Owner receives
an offer to purchase the Property during the option period, the Company will have a right of first refusal to purchase the Property
on the same terms as the offer. Should the Company elect not to match the offer, the Option Payment is required to be repaid
upon the sale of the Property to the other buyer.
On March 12, 2014, the Company entered into
a Purchase and Sale Agreement (the “PS Agreement”) with the Property Owner. The Option Payment was converted into a “Deposit”
against the purchase of the property and shall continue to accrue interest at the rate of 12% per annum,from the date of the Option
Agreement through the date of the purchase of the Property. The property will not be purchased prior to August 1, 2014.
Note 7 – Stockholders’
Equity (Deficit)
Shares Authorized
Upon formation the total number of shares
of all classes of stock which the Company is authorized to issue is Two Hundred Million (200,000,000) shares of which One
Hundred Million (100,000,000) shares shall be Preferred Stock, par value $0.001 per share, and One Hundred Million
(100,000,000) shares shall be Common Stock, par value $0.001 per share.
Common Stock
Amendment to the Articles of
Incorporation to Effectuate a Reverse Stock Split
Effective December 4, 2012, the Board of Directors
and the majority voting stockholders adopted and approved a resolution to amend its Articles of Incorporation to effectuate a reverse
split of all issued and outstanding shares of common stock, at a ratio of thirty five-for one (35:1) (the “Reverse Stock Split”)..
All shares and per share amounts in the financial
statements have been adjusted to give retroactive effect to the Stock Split.
Issuance of Common Stock
On July 23, 2012, the Company issued 1,000,000
shares of common stock, at $0.035 per share for gross proceeds of $35,000.
On March 28, 2013, the Company entered
into a share for debt agreement whereby it issued 10,000,000 shares of its common stock in exchange for the extinguishment of
$35,000 in debt to a related party.
Warrants
Summary of the Company’s
Warrants Activities
The table below summarizes the Company’s warrants
activities:
|
|
Number
of Warrant Shares
|
|
|
Exercise
Price Range Per Share
|
|
|
Weighted
Average Exercise Price
|
|
|
Relative
Fair Value at Date of Issuance
|
|
|
Aggregate
Intrinsic Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2013
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
2,310,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
$
|
Xxx,xxx
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canceled
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(—
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2013
|
|
|
2,310,000
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
$
|
Xxx,xxx
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned and exercisable, December 31, 2013
|
|
|
2,310,000
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
$
|
Xxx,xxx
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested, December 31, 2013
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
The following table summarizes information
concerning outstanding and exercisable warrants as of December 31, 2013:
|
|
Warrants Outstanding
|
|
Warrants Exercisable
|
|
Range of Exercise Prices
|
|
Number Outstanding
|
|
Average Remaining Contractual Life
(in years)
|
|
Weighted Average Exercise Price
|
|
Number Exercisable
|
|
Average Remaining Contractual Life
(in years)
|
|
Weighted Average Exercise Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$1.00
|
|
|
2,,310,000
|
|
|
4.94
|
|
$
|
1.00
|
|
|
2,30,000
|
|
|
4.94
|
|
$
|
1.00
|
|
Note 8 – Income Tax
Provision
Deferred Tax Assets
At December 31, 2013, the Company had net operating
loss (“NOL”) carry–forwards for Federal income tax purposes of $460,645 that may be offset against future taxable
income through 2033. No tax benefit has been reported with respect to these net operating loss carry-forwards in the accompanying
financial statements because the Company believes that the realization of the Company’s net deferred tax assets of approximately
$156,619 was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are
fully offset by a valuation allowance of $156,619.
Deferred tax assets consist primarily
of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because
of the uncertainty regarding its realization. The valuation allowance increased approximately $13,573 for the reporting period
ended December 31.
Components of deferred tax assets are as follows:
|
|
December 31,
2013
|
|
|
September 30,
2013
|
|
|
September 30,
2012
|
|
Net deferred tax assets – Non-current:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected income tax benefit from NOL carry-forwards
|
|
|
156,619
|
|
|
|
143,046
|
|
|
|
134,717
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less valuation allowance
|
|
|
(156,619
|
)
|
|
|
(143,046
|
)
|
|
|
(134,717
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
tax assets, net of valuation allowance
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Income Tax Provision in the Statements of
Operations
A reconciliation of the federal statutory income tax rate and the
effective income tax rate as a percentage of income before income taxes is as follows:
|
|
For the Three Months Ended December 31,
2013
|
|
|
For the Fiscal Year Ended September 30,
2013
|
|
|
For
the Fiscal Year Ended September 30,
2012
|
|
|
|
|
|
|
|
|
|
|
|
Federal statutory income tax rate
|
|
|
34.0
|
%
|
|
|
34.0
|
%
|
|
|
35.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in valuation allowance on net operating loss carry-forwards
|
|
|
(34.0
|
)
|
|
|
(34.0
|
)
|
|
|
(35.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
Note 9 – Subsequent
Events
The Company has evaluated all events that occur
after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.
The Management of the Company determined that there were no reportable subsequent events to be disclosed.
F-19
CalEthos (PK) (USOTC:BUUZ)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
CalEthos (PK) (USOTC:BUUZ)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024